Gert Storm,
#109,514
Most Influential Person Now
Gert Storm,'s AcademicInfluence.com Rankings
Gert Storm,biology Degrees
Biology
#5975
World Rank
#8586
Historical Rank
Biotechnology
#50
World Rank
#51
Historical Rank
Cell Biology
#172
World Rank
#179
Historical Rank
Molecular Biology
#587
World Rank
#601
Historical Rank
Download Badge
Biology
Why Is Gert Storm, Influential?
(Suggest an Edit or Addition)Gert Storm,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endosomal escape pathways for delivery of biologicals. (2011) (1242)
- Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. (2012) (1134)
- Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. (2004) (882)
- Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system (1995) (831)
- Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. (2017) (787)
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release (2010) (772)
- In situ gelling hydrogels for pharmaceutical and biomedical applications. (2008) (544)
- Tumour-targeted nanomedicines: principles and practice (2008) (529)
- Sheddable Coatings for Long-Circulating Nanoparticles (2007) (513)
- Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization (2018) (462)
- Theranostic nanomedicine. (2020) (461)
- Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. (2006) (448)
- Nanotheranostics and image-guided drug delivery: current concepts and future directions. (2010) (354)
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. (2013) (347)
- Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. (2015) (343)
- Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. (1997) (323)
- Liposomes to target the lymphatics by subcutaneous administration. (2001) (309)
- Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. (2003) (305)
- Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. (2003) (281)
- Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. (2005) (280)
- Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. (1993) (274)
- Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. (2013) (271)
- MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle (2005) (270)
- Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. (2011) (268)
- Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. (2014) (263)
- Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. (2010) (236)
- Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. (2009) (230)
- The battle of “nano” paclitaxel (2017) (228)
- A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. (2004) (227)
- Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. (2007) (220)
- Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. (2000) (214)
- Multidrug resistance: Physiological principles and nanomedical solutions. (2013) (210)
- Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. (2004) (202)
- A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. (2003) (195)
- Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. (2009) (189)
- Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. (2003) (183)
- Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. (2003) (182)
- Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges. (2016) (181)
- Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. (2011) (179)
- Targeting tumor antigens to dendritic cells using particulate carriers. (2012) (179)
- ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES (2002) (177)
- Micelles based on HPMA copolymers. (2010) (175)
- Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. (2009) (174)
- Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins* (2002) (171)
- Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation (2015) (171)
- Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. (2011) (170)
- Towards clinical translation of ligand‐functionalized liposomes in targeted cancer therapy: Challenges and opportunities (2018) (169)
- Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. (2006) (167)
- Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. (2017) (166)
- The role of liposomes in clinical nanomedicine development. What now? Now what? (2019) (161)
- Cancer nanomedicine: Is targeting our target? (2016) (160)
- Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles. (2015) (160)
- Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion (2004) (154)
- Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. (2010) (153)
- Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis (2004) (150)
- Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. (2005) (148)
- Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. (2007) (146)
- A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. (2003) (145)
- Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. (2001) (143)
- Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. (2012) (142)
- Steric stabilization of poly(2‐(dimethylamino)ethyl methacrylate)‐based polyplexes mediates prolonged circulation and tumor targeting in mice (2004) (142)
- Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. (2006) (140)
- Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. (2012) (134)
- Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. (1993) (132)
- Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. (2006) (129)
- Downregulation of EGFR by a novel multivalent nanobody-liposome platform. (2010) (122)
- Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots (2008) (122)
- Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. (2005) (121)
- Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy (2008) (121)
- Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells. (2010) (120)
- Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy (2010) (119)
- Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. (2015) (119)
- Dexamethasone nanomedicines for COVID-19 (2020) (119)
- Liposomal drug formulations in the treatment of rheumatoid arthritis. (2011) (118)
- Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation (2015) (116)
- Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. (2014) (116)
- Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy. (2013) (116)
- SiRNA delivery with functionalized carbon nanotubes. (2011) (115)
- Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery (2018) (115)
- Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. (2005) (114)
- OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. (2004) (113)
- Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. (1987) (112)
- Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. (2016) (112)
- Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. (2002) (112)
- Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer (2017) (112)
- Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems. (2007) (111)
- Liposomes in the treatment of inflammatory disorders (2005) (111)
- Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma (2014) (110)
- Nanomedicines as cancer therapeutics: current status. (2013) (110)
- Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. (2015) (108)
- MicroRNA Targeting to Modulate Tumor Microenvironment (2016) (108)
- Gold nanoparticles in theranostic oncology: current state-of-the-art (2012) (107)
- Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration. (2016) (107)
- In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay. (2013) (106)
- Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. (2007) (105)
- Ultrasound-mediated drug delivery to the brain: principles, progress and prospects. (2016) (105)
- Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. (2007) (104)
- Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems. (2006) (104)
- Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. (2003) (104)
- Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA. (2007) (103)
- Nanotechnological approaches for the delivery of macromolecules. (2003) (102)
- Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative (2017) (102)
- Doxorubicin decomposition on storage: effect of pH, type of buffer and liposome encapsulation (1985) (102)
- Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases. (2015) (102)
- Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. (2012) (102)
- The therapeutic equivalence of complex drugs. (2011) (101)
- Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery. (2017) (101)
- Enhancing photodynamic therapy of refractory solid cancers : Combining second-generation photosensitizers with multi-targeted liposomal delivery (2015) (100)
- Noninvasive optical imaging of nanomedicine biodistribution. (2013) (99)
- Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. (2008) (98)
- Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes. (1998) (95)
- Neovascular Age-Related Macular Degeneration (2011) (95)
- Personalized Nanomedicine (2012) (94)
- Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV-TAT peptide and octaarginine. (2006) (93)
- In Vivo Methods to Study Uptake of Nanoparticles into the Brain (2010) (91)
- Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction (2017) (90)
- Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. (1992) (89)
- Drug targeting systems for inflammatory disease: one for all, all for one. (2012) (86)
- Early in vivo assessment of angiostatic therapy efficacy by molecular MRI (2007) (83)
- The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. (2001) (83)
- Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes. (2007) (82)
- Peptide-targeted PEG-liposomes in anti-angiogenic therapy. (2003) (82)
- Nanobody-shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting. (2011) (82)
- Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicity (2011) (81)
- Lymphatic Uptake and Biodistribution of Liposomes After Subcutaneous Injection: III. Influence of Surface Modification with Poly(ethyleneglycol) (1997) (81)
- Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. (2014) (80)
- Nanomedicine Strategies to Target Tumor-Associated Macrophages (2017) (80)
- Immune cell screening of a nanoparticle library improves atherosclerosis therapy (2016) (79)
- Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles. (2015) (79)
- Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment. (2012) (78)
- Liposomes: From the Bench to the Bed (2003) (78)
- In Vitro Cellular Handling and in Vivo Targeting of E-Selectin-Directed Immunoconjugates and Immunoliposomes Used for Drug Delivery to Inflamed Endothelium (2004) (77)
- Sonochemotherapy: from bench to bedside (2015) (77)
- Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs. (2015) (77)
- Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. (1996) (76)
- Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level. (2013) (75)
- Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. (2007) (75)
- MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor (2016) (75)
- Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. (2010) (75)
- Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. (2001) (75)
- Optimization of intradermal vaccination by DNA tattooing in human skin. (2008) (75)
- Effects of Physicochemical Characteristics of Poly(2-(dimethylamino)ethyl methacrylate)-Based Polyplexes on Cellular Association and Internalization (2000) (75)
- Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. (1988) (73)
- Physicochemical and Biological Evaluation of siRNA Polyplexes Based on PEGylated Poly(amido amine)s (2011) (72)
- Liposomal corticosteroids for the treatment of inflammatory disorders and cancer. (2014) (71)
- Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. (2006) (71)
- Nano‐targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo (2018) (69)
- Targeted Delivery of siRNA (2006) (69)
- Diagnostic and therapeutic strategies for small abdominal aortic aneurysms (2011) (68)
- Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. (2014) (68)
- The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy. (2011) (66)
- Temperature-sensitive poly(N-(2-hydroxypropyl)methacrylamide mono/dilactate)-coated liposomes for triggered contents release. (2007) (65)
- Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells. (2008) (64)
- Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. (1999) (64)
- Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens. (2015) (63)
- Extracellular vesicles as a drug delivery system:A systematic review of preclinical studies. (2021) (63)
- Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation (2018) (63)
- Lanthanide-loaded liposomes for multimodality imaging and therapy. (2006) (63)
- Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan. (2010) (62)
- Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. (2007) (62)
- The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis (2015) (62)
- Molecular biology of epidermal growth factor receptor inhibition for cancer therapy (2006) (62)
- In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. (1992) (62)
- Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes. (2012) (61)
- In vivo tumor transfection mediated by polyplexes based on biodegradable poly(DMAEA)-phosphazene. (2005) (60)
- Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier (2010) (60)
- Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice (2008) (60)
- ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer (2019) (59)
- Evidence for a new mechanism behind HIFU-triggered release from liposomes. (2013) (58)
- Therapeutic Application of Long-Circulating Liposomal Glucocorticoids in Auto-Immune Diseases and Cancer (2006) (58)
- Hyperthermia‐Induced Drug Delivery from Thermosensitive Liposomes Encapsulated in an Injectable Hydrogel for Local Chemotherapy (2014) (58)
- Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity. (2011) (57)
- Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. (2012) (57)
- A new application for liposomes in cancer therapy (1993) (57)
- Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12. (2018) (56)
- Nanopolymersomes with an Ultrahigh Iodine Content for High‐Performance X‐Ray Computed Tomography Imaging In Vivo (2017) (56)
- Immunoliposomes in vivo. (1994) (56)
- Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system. (1998) (56)
- Host Factors Influencing the Preferential Localization of Sterically Stabilized Liposomes in Klebsiella Pneumoniae-Infected Rat Lung Tissue (2004) (56)
- Contribution of Classic and Alternative Effector Pathways in Peanut-Induced Anaphylactic Responses (2011) (56)
- Overcoming cellular multidrug resistance using classical nanomedicine formulations. (2012) (56)
- Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo. (2020) (56)
- Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells. (2005) (55)
- Targeted drug delivery systems for the intracellular delivery of macromolecular drugs. (2003) (55)
- Complement activation by PEGylated liposomes containing prednisolone. (2013) (54)
- Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2‐(dimethylamino)ethyl methacrylate)‐based polyplexes (1999) (54)
- Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's Disease (2000) (53)
- Radiopharmaceuticals for scintigraphic imaging of infection and inflammation (2001) (53)
- Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles. (2017) (53)
- MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model. (2012) (53)
- Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units. (2007) (52)
- Disulfide-Based Poly(amido amine)s for siRNA Delivery: Effects of Structure on siRNA Complexation, Cellular Uptake, Gene Silencing and Toxicity (2010) (52)
- Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. (2003) (52)
- Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. (2010) (52)
- MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses. (2015) (52)
- Liposomes Containing Interferon-Gamma as Adjuvant in Tumor Cell Vaccines (2004) (51)
- Triggered release of doxorubicin from temperature-sensitive poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes. (2014) (51)
- Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis. (2011) (50)
- Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant. (2016) (50)
- Optimization of poly(amido amine)s as vectors for siRNA delivery. (2011) (50)
- Technetium-99m labelled liposomes to image experimental arthritis (1997) (50)
- Endothelial cells at inflammatory sites as target for therapeutic intervention. (2002) (50)
- Formulation and characterization of microspheres loaded with imatinib for sustained delivery. (2015) (50)
- Long-circulating sterically stabilized liposomes in the treatment of infections. (2005) (50)
- Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes. (2012) (49)
- Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry. (2011) (49)
- Polyplexes based on cationic polymers with strong nucleic acid binding properties. (2012) (49)
- Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer (2015) (49)
- Duration of ultrasound-mediated enhanced plasma membrane permeability. (2015) (48)
- MRI of ICAM-1 Upregulation After Stroke: the Importance of Choosing the Appropriate Target-Specific Particulate Contrast Agent (2013) (48)
- Liposomal nanomedicines in the treatment of prostate cancer. (2014) (47)
- Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation (2013) (47)
- Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. (1999) (47)
- Liposomes in the treatment of infections. (1994) (46)
- Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. (2018) (46)
- From design to the clinic: practical guidelines for translating cardiovascular nanomedicine (2018) (46)
- Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy (2015) (45)
- Liposome-Mediated Targeting of Enzymes to Cancer Cells for Site-Specific Activation of Prodrugs: Comparison with the Corresponding Antibody-Enzyme Conjugate (2003) (45)
- Cytosolic Delivery of Liposomally Targeted Proteins Induced by Photochemical Internalization (2007) (45)
- Subcutaneous Administration of Superoxide Dismutase Entrapped in Long Circulating Liposomes: In Vivo Fate and Therapeutic Activity in an Inflammation Model (2000) (45)
- Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells (2001) (44)
- Effect of Liposome Characteristics and Dose on the Pharmacokinetics of Liposomes Coated with Poly(amino acid)s (2007) (44)
- Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes. (2004) (44)
- Biodegradable Poly(2-Dimethylamino Ethylamino)Phosphazene for In Vivo Gene Delivery to Tumor Cells. Effect of Polymer Molecular Weight (2007) (44)
- Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases (2017) (43)
- Delivery of siRNA to the target cell cytoplasm: photochemical internalization facilitates endosomal escape and improves silencing efficiency, in vitro and in vivo. (2008) (43)
- Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer. (2016) (43)
- Immunoliposomes in vivo: state of the art (1988) (43)
- Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing. (2018) (42)
- The hepatic lipidome: From basic science to clinical translation. (2020) (42)
- Liposomes and biotherapeutics (1991) (42)
- Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo (2015) (41)
- Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach (2011) (41)
- Gene silencing activity of siRNA polyplexes based on biodegradable polymers. (2011) (41)
- Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles. (2012) (41)
- Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting. (2012) (40)
- Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. (2015) (40)
- Image-guided drug delivery: preclinical applications and clinical translation (2015) (40)
- Transporting silence: design of carriers for siRNA to angiogenic endothelium. (2005) (40)
- Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating. (2000) (40)
- Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model (2017) (39)
- Granzyme B‐loaded, cell‐selective penetrating and reduction‐responsive polymersomes effectively inhibit progression of orthotopic human lung tumor in vivo (2018) (39)
- Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice. (2008) (39)
- Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. (2011) (39)
- Comparison of Polymeric siRNA Nanocarriers in a Murine LPS-Activated Macrophage Cell Line: Gene Silencing, Toxicity and Off-Target Gene Expression (2012) (38)
- Thermally triggered release of a pro-osteogenic peptide from a functionalized collagen-based scaffold using thermosensitive liposomes. (2014) (38)
- Sunitinib microspheres based on [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers for ocular drug delivery. (2015) (38)
- Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells. (2008) (38)
- A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis. (2017) (37)
- Design of immunoliposomes directed against human ovarian carcinoma. (1995) (37)
- Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine). (2005) (37)
- The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. (1998) (36)
- Strategies for cytosolic delivery of liposomal macromolecules. (2005) (36)
- Prolonged Systemic Delivery of Peptide Drugs by Long-Circulating Liposomes: Illustration with Vasopressin in the Brattleboro Rat (1992) (36)
- Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes (2020) (36)
- Colloidal systems for tumor targeting. (1997) (35)
- Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil (2008) (35)
- Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles. (2012) (35)
- Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization (2015) (35)
- ACTIVE TARGETING WITH PARTICULATE CARRIER SYSTEMS IN THE BLOOD COMPARTMENT (1995) (35)
- In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime. (2001) (35)
- Lymphatic Uptake and Biodistribution of Liposomes after Subcutaneous Injection I. Influence of the Anatomical Site of Injection (1997) (34)
- Applying nanomedicine in maladaptive inflammation and angiogenesis. (2017) (34)
- Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation (2014) (34)
- Port wine stain treatment outcomes have not improved over the past three decades (2019) (34)
- Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG. (1999) (34)
- Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis. (2011) (34)
- MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate. (2012) (33)
- DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations. (2011) (33)
- Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate‐containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats (2012) (33)
- A method for quantifying cellular uptake of fluorescently labeled siRNA. (2010) (33)
- CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis (2005) (33)
- Biosynthetically lipid‐modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes (1996) (33)
- Plasmid CpG Depletion Improves Degree and Duration of Tumor Gene Expression After Intravenous Administration of Polyplexes (2008) (32)
- Synthetic vehicles for DNA vaccination (2009) (32)
- Novel developments in liposomal delivery of peptides and proteins (1995) (32)
- Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology. (2001) (32)
- Increase of intracellular cisplatin levels and radiosensitization by ultrasound in combination with microbubbles. (2016) (32)
- Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment (2016) (32)
- Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti–Fibroblast Activation Protein Antibody (2017) (32)
- Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration. (1999) (31)
- Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity (2014) (31)
- Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin (2005) (31)
- Head-to-Head Comparison of Anti-Inflammatory Performance of Known Natural Products In Vitro (2016) (31)
- Therapeutic Efficacy of Liposome-Encapsulated Gentamicin in Rat Klebsiella pneumoniae Pneumonia in Relation to Impaired Host Defense and Low Bacterial Susceptibility to Gentamicin (2001) (31)
- Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines (2022) (31)
- Trends in polymeric delivery of nucleic acids to tumors. (2013) (31)
- Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging. (2012) (31)
- Radionuclide imaging of liposomal drug delivery (2016) (30)
- Targeting liposomes to tumor endothelial cells for neutron capture therapy. (2004) (30)
- Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo. (2019) (30)
- Complement activation in vitro and reactogenicity of low‐molecular weight dextran‐coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information (2018) (30)
- In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses. (2015) (30)
- Comparison of pharmaceutical nanoformulations for curcumin: Enhancement of aqueous solubility and carrier retention. (2016) (30)
- Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins (1997) (30)
- E‐selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells (2017) (29)
- Inhibition of tumor growth by targeted anti-EGFR/IGF-1R nanobullets depends on efficient blocking of cell survival pathways. (2013) (29)
- Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non‐alcoholic steatohepatitis (2018) (29)
- Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells (2012) (29)
- Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin (2015) (29)
- Targeting influenza virosomes to ovarian carcinoma cells (2001) (29)
- An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. (2011) (29)
- A novel approach for the intravenous delivery of leuprolide using core-cross-linked polymeric micelles. (2015) (28)
- Reprint of "Nanobody--shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting". (2011) (28)
- Sterically stabilized amphotericin B-liposomes : toxicity and biodistribution in mice (1995) (28)
- Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis (2018) (28)
- TARGETED LIPOSOMES FOR DELIVERY OF PROTEIN-BASED DRUGS INTO THE CYTOPLASM OF TUMOR CELLS (2002) (28)
- Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes. (2017) (27)
- Immunoliposomes as Enzyme-Carriers (Immuno-Enzymosomes) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT): Optimization of Prodrug Activating Capacity (1996) (27)
- Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow: A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells (2013) (27)
- Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma (2008) (27)
- Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide. (2011) (27)
- Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications. (2016) (26)
- Cancer nanomedicine meets immunotherapy: opportunities and challenges (2020) (26)
- Liposomes as carriers for colchicine-derived prodrugs: vascular disrupting nanomedicines with tailorable drug release kinetics. (2012) (26)
- Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor (2019) (25)
- Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. (2021) (25)
- Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis. (2019) (25)
- Polymeric carrier systems for siRNA delivery. (2012) (25)
- Effect of Repeated Intravenous Administration on the Circulation Kinetics of Poly(Ethyleneglycol)-Liposomes in Rats (1999) (25)
- Immunoadjuvant activity of interferon-γ-liposomes co-administered with influenza vaccines (2001) (25)
- Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cells. (2017) (25)
- [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. (2015) (24)
- Enzyme-induced shedding of a poly(amino acid)-coating triggers contents release from dioleoyl phosphatidylethanolamine liposomes. (2008) (24)
- Attaching the phage display-selected GLA peptide to liposomes: factors influencing target binding. (2012) (24)
- Comparison of three remote radiolabelling methods for long-circulating liposomes. (2015) (24)
- Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells. (1998) (23)
- A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat (2004) (23)
- Erythrophagocytosis by angiogenic endothelial cells is enhanced by loss of erythrocyte deformability. (2010) (23)
- Biodegradable, cationic methacrylamide-based polymers for gene delivery to ovarian cancer cells in mice. (2008) (23)
- Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo. (2021) (23)
- Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits (2013) (22)
- Interaction of recombinant interleukin-2 with liposomal bilayers. (1998) (22)
- Liposomal dexamethasone inhibits tumor growth in an advanced human‐mouse hybrid model of multiple myeloma (2019) (22)
- Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis (2018) (22)
- Imatinib-ULS-lysozyme: a proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases. (2012) (22)
- Liposome encapsulation of doxorubicin: Pharmaceutical and therapeutic aspects (1989) (22)
- Cationic polymeric gene delivery of β‐glucuronidase for doxorubicin prodrug therapy (1999) (22)
- Liposome-induced hypersensitivity reactions: Risk reduction by design of safe infusion protocols in pigs. (2019) (22)
- Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid‐based thermosensitive liposomes (2017) (22)
- Renal targeting of kinase inhibitors. (2008) (21)
- In situ Delivery of Tumor Antigen- and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells. (2015) (21)
- A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy (2011) (21)
- Histidine‐rich glycoprotein‐induced vascular normalization improves EPR‐mediated drug targeting to and into tumors (2018) (21)
- Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors. (2008) (21)
- Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines. (2012) (21)
- Eradication of Medullary Multiple Myeloma by CD4+ Cytotoxic Human T Lymphocytes Directed at a Single Minor Histocompatibility Antigen (2010) (21)
- Locoregional cancer therapy using polymer-based drug depots. (2016) (21)
- Π electron-stabilized polymeric micelles potentiate docetaxel therapy in advanced-stage gastrointestinal cancer. (2020) (21)
- Liposomes as drug carrier system for cis-diamminedichloroplatinum (II) (1988) (21)
- ICS-283: a system for targeted intravenous delivery of siRNA (2006) (21)
- Liposome‐mediated peptide loading of MHC‐DR molecules in vivo (1997) (20)
- Liposomes: The Science and the Regulatory Landscape (2015) (20)
- 'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems. (2011) (20)
- Targeting to lymph nodes by subcutaneous administration of liposomes (1998) (20)
- A comparative study of different cationic transfection agents for in vivo gene delivery after intravenous administration (2004) (19)
- Radiolabeling of liposomes for scintigraphic imaging. (2003) (19)
- Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo. (2019) (19)
- Development of a cell-selective and intrinsically active multikinase inhibitor bioconjugate. (2011) (19)
- Tumor vasculature as target for therapeutic intervention (2010) (19)
- Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles. (2020) (18)
- Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of anticancer prodrugs (1997) (18)
- Liposomes in treatment of infectious diseases (1987) (18)
- Antibody-Targeted Liposomes to Deliver Doxorubicin to Ovarian Cancer Cells (1994) (18)
- Alginate microgels loaded with temperature sensitive liposomes for magnetic resonance imageable drug release and microgel visualization (2015) (18)
- HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations. (2010) (18)
- Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo. (2020) (18)
- CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity (2021) (17)
- Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall. (2019) (17)
- Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation (2020) (17)
- PEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses. (2014) (17)
- Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue. (2012) (17)
- LIGAND-TARGETED LIPOSOMES DIRECTED AGAINST PATHOLOGICAL VASCULATURE (2002) (17)
- Alveolar macrophages have a dual role in a rat model for trimellitic anhydride-induced occupational asthma. (2006) (16)
- Liposomes and immunoliposomes for controlled release or site specific delivery of anti-parasitic drugs and cytostatics (1991) (16)
- Alveolar macrophages suppress non-specific inflammation caused by inhalation challenge with trimellitic anhydride conjugated to albumin (2006) (16)
- Liposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detection. (1999) (16)
- Synthetic delivery systems for intravenous administration of nucleic acids. (2007) (16)
- Inhibition of M1 macrophage activation in favour of M2 differentiation by liposomal targeting of glucocorticoids to the synovial lining during experimental arthritis (2011) (16)
- Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality. (2007) (16)
- Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies (2012) (16)
- Development and characterization of liposomal formulation of bortezomib (2019) (16)
- A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes (2018) (16)
- Biopharmaceutical aspects of lipid formulations of amphotericin B (2005) (16)
- Fluorophore labeling of core-crosslinked polymeric micelles for multimodal in vivo and ex vivo optical imaging. (2015) (15)
- Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant? (2010) (15)
- Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134 (2008) (15)
- Macromolecular nanotheranostics for multimodal anticancer therapy. (2011) (15)
- New insights into the HIFU-triggered release from polymeric micelles. (2013) (15)
- Setting standards to promote progress in bio–nano science (2019) (15)
- Nanomedicine formulations for combination therapies (2010) (15)
- Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study. (2012) (15)
- Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1 (2021) (14)
- CD64-Targeted Prednisolone Lipid Nanoparticles As a Novel Drug Delivery System to Target Inflammatory Macrophages for the Treatment of Alcoholic Liver Diseases (2018) (14)
- Liposomal prednisolone inhibits tumor growth in a spontaneous mouse mammary carcinoma model. (2016) (14)
- Public-private partnerships in translational medicine: concepts and practical examples. (2012) (14)
- Nanoclusters of iron oxide: effect of core composition on structure, biocompatibility, and cell labeling efficacy. (2012) (14)
- Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models. (2001) (14)
- Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties. (1999) (14)
- Utility of Targeted Glucocorticoids in Cancer Therapy (2008) (14)
- Conformational stability of human interferon-gamma on association with and dissociation from liposomes. (2000) (14)
- Clinical outcome measures and scoring systems used in prospective studies of port wine stains: A systematic review (2020) (13)
- Processing of Doxorubicin-Containing Liposomes by Liver Macrophages in Vitro (1989) (13)
- Administration of prednisolone phosphate–liposomes reduces wound contraction in a rat partial‐thickness wound model (2006) (13)
- Liposomes as a drug carrier system for cis-diamminedichloroplatinum (II). I. Binding capacity, stability and tumor cell growth inhibition in vitro (1987) (13)
- Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines. (2001) (13)
- Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumor. (1987) (13)
- Liposomes with asymmetric bilayers produced from inverse emulsions for nucleic acid delivery (2019) (13)
- Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system (2010) (13)
- TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo (2019) (13)
- 5th International Symposium on Focused Ultrasound (2016) (13)
- Role of spleen tyrosine kinase in liver diseases (2020) (13)
- Liposomal doxorubicin: the good, the bad and the not-so-ugly (2016) (12)
- Physicochemical and biopharmaceutical characterization of dipalmitoyl phosphatidylcholine liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units (2010) (12)
- Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages (2020) (12)
- Utility of targeted glucocorticoids in cancer therapy. (2008) (12)
- Liposomal targeting of angiogenic vasculature. (2005) (12)
- Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro (2019) (12)
- Site-specific pharmaco-laser therapy: A novel treatment modality for refractory port wine stains (2019) (12)
- Shelf-Life Evaluation and Lyophilization of PBCA-Based Polymeric Microbubbles (2019) (12)
- Targeted delivery of anti-inflammatory agents to tumors. (2009) (12)
- High-resolution 3D visualization of nanomedicine distribution in tumors (2020) (11)
- siRNA-mediated inhibition of angiogenesis (2005) (11)
- Lyophilization stabilizes clinical‐stage core‐crosslinked polymeric micelles to overcome cold chain supply challenges (2021) (11)
- Targeted delivery of diphtheria toxin via immunoliposomes: efficient antitumor activity in the presence of inactivating anti‐diphtheria toxin antibodies (1996) (11)
- FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor (2020) (11)
- TAT-peptide modified liposomes: preparation, characterization, and cellular interaction. (2010) (11)
- A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system. (2021) (11)
- Lipogels responsive to near-infrared light for the triggered release of therapeutic agents. (2017) (11)
- Opportunities in targeted drug delivery to Kupffer cells: delivery of immunomodulators to Kupffer cells-activation of tumoricidal properties (1995) (11)
- Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids (2011) (11)
- 1H NMR spectroscopy as a tool for determining the composition of poly(hydroxyethyl-L-asparagine)-coated liposomes. (2006) (11)
- Erratum: Cancer nanomedicine: is targeting our target? (2016) (10)
- Potential therapeutic benefits stemming from the thermal nature of irreversible electroporation of solid cancers. (2015) (10)
- Systematic Evaluation of Design Features Enables Efficient Selection of Π Electron-Stabilized Polymeric Micelles. (2020) (10)
- Anginex lipoplexes for delivery of anti-angiogenic siRNA. (2014) (10)
- Administration of liposomal agents and the phagocytic function of the mononuclear phagocyte system (1998) (10)
- Intercalating quaternary nicotinamide-based poly(amido amine)s for gene delivery. (2014) (10)
- Targeting the retinal microcirculation to treat diabetic sight problems (2007) (10)
- Liposomes targeting tumour stromal cells (2010) (10)
- Photochemical internalization (PCI)-mediated enhancement of gene silencing efficiency of polymethacrylates and N,N,N-trimethylated chitosan (TMC) based siRNA polyplexes. (2010) (10)
- Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy (2019) (10)
- Local sustained delivery of bupivacaine HCl from a new castor oil-based nanoemulsion system (2018) (10)
- Anti-Inflammatory Properties of Plant Derived Natural Products - A Systematic Review. (2019) (9)
- Potential pitfalls in in vitro antitumor activity testing of free and liposome-entrapped doxorubicin. (1988) (9)
- Targeting cellular and microenvironmental multidrug resistance (2016) (9)
- Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats (2020) (9)
- Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections. (2018) (9)
- Drug-laden liposomes in antitumor therapy and in the treatment of parasitic diseases. (1990) (9)
- Application of cultured human regulatory T cells requires preclinical in vivo evaluation. (2012) (9)
- Liposomes as cytokine-supplement in tumor cell-based vaccines. (1999) (8)
- Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. (2016) (8)
- A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release. (2011) (8)
- Scale-Up of the Manufacturing Process To Produce Docetaxel-Loaded mPEG-b-p(HPMA-Bz) Block Copolymer Micelles for Pharmaceutical Applications (2019) (8)
- LIPOSOME-ENABLED SYNERGISTIC INTERACTION OF ANTIMICROBIAL AGENTS (2002) (8)
- Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo (2015) (8)
- Liposomes for Local Sustained Drug Release (2000) (8)
- Lyophilization of TC-99m-Hynic Labeled Peg-Liposomes (2000) (8)
- Preclinical evaluation of thermosensitive poly(N‐(2‐hydroxypropyl) methacrylamide mono/dilactate)‐grafted liposomes for cancer thermochemotherapy (2018) (8)
- Relaxin-coated superparamagnetic iron-oxide nanoparticles as a novel theranostic approach for the diagnosis and treatment of liver fibrosis (2017) (7)
- A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation (2020) (7)
- Targeting of Antibiotics in Bacterial Infections Using Pegylated Long-Circulating Liposomes (2000) (7)
- Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion. (2021) (7)
- Liposomes as delivery system for doxorubicin in cancer chemotherapy. (1988) (7)
- Tumor cell and tumor vasculature targeted liposomes for neutron capture therapy (2005) (7)
- SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES FOR LYMPHATIC TARGETING (1997) (7)
- Liposomal Delivery of Peptides and Proteins (1995) (6)
- Absolute MR thermometry using nanocarriers. (2014) (6)
- Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. (2021) (6)
- Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis. (2002) (6)
- Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration. (2015) (6)
- Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes (1998) (6)
- Dynamic Fluorescence Microscopy of Cellular Uptake of Intercalating Model Drugs by Ultrasound-Activated Microbubbles (2017) (6)
- The possible role of factor H in complement activation-related pseudoallergy (CARPA): a failed attempt to correlate blood levels of FH with liposome-induced hypersensitivity reactions in patients with autoimmune disease (2015) (6)
- Quick-and-easy preparation and purification of quantum dot–loaded liposomes (2012) (6)
- Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization (2021) (6)
- Chemical stability of n trifluoroacetyldoxorubicin 14 valerate ad 32 in aqueous media and after liposome encapsulation (1989) (5)
- Environmental impact of switching from the synthetic glucocorticoid prednisolone to the natural alkaloid berberine (2018) (5)
- Targeting of peptide and protein drugs (1994) (5)
- Treatment Outcome Measurement Instruments for Port Wine Stains: A Systematic Review of Their Measurement Properties (2020) (5)
- Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines (2021) (5)
- ITGA 5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer (2019) (5)
- Critical evaluation of quantification methods for oligonucleotides formulated in lipid nanoparticles (2017) (5)
- Hybrid Materials: Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation (Adv. Funct. Mater. 1/2015) (2015) (5)
- Endogenous or Exogenous Retinal Pigment Epithelial Cells: A Comparison of Two Experimental Animal Models of Proliferative Vitreoretinopathy (2020) (5)
- Apoptosis-inducing Peptide Loaded in PLGA Nanoparticles Induces Anti-tumor Effects In Vivo. (2020) (5)
- The Design of a Pharmaceuttcally Acceptable Liposomal Formulation of Recombinant Interleukin-2 (Ril-2) for Locoregional Anticancer Immunotherapy (1999) (4)
- Bimodal Liposomes and Paramagnetic QD-Micelles for Multimodality Molecular Imaging of Tumor Angiogenesis (2008) (4)
- High systemic availability of core-crosslinked polymeric micelles after subcutaneous administration. (2016) (4)
- Detection of infection and inflammation with technetium-99m-labeled PEG-liposomes (1999) (4)
- CONSTRUCTION OF ENZYMOSOMES: OPTIMIZATION OF COUPLING PARAMETERS (2006) (4)
- Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat peritoneal exudate cell populations. (1996) (4)
- Preparation and characterization of liposomal formulations of neurotensin-degrading enzyme inhibitors. (2011) (4)
- UEG Week 2016 Poster Presentations (2016) (4)
- ZnO Nano-Rod Devices for Intradermal Delivery and Immunization (2017) (4)
- Imaged-guided focused ultrasound in combination with various formulations of doxorubicin for the treatment of diffuse intrinsic pontine glioma (2022) (4)
- Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application (2021) (4)
- Pharmacokinetics of liposomes designed to carry glucocorticoids. (2003) (3)
- Tumor targeted delivery of siRNA. (2004) (3)
- Pharmaceutical Nanocarriers in Treatment and Imaging of Infection (2006) (3)
- Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma (2020) (3)
- Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management. (2022) (3)
- Multimodal imaging of breast cancer metastasis targeting and antimetastatic nanotherapy (2016) (3)
- Polymers for drug delivery: the debate continues. (2003) (3)
- Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses (2022) (3)
- Distribution of technetium-99m PEG-liposomes during oligofructose-induced laminitis development in horses. (2015) (3)
- Hemocompatibility Assessment of two siRNA Nanocarrier Formulations (2014) (3)
- Targeting integrin alpha5 receptor in pancreatic stellate cells to diminish tumor-promoting effects in pancreatic cancer (2018) (3)
- A scintigraphic comparison of 99mTc labelled IgG, PEG-liposome and leukocyte accumulation in experimentally induced focal soft tissue infection in the horse (2011) (3)
- Carrier-based radiochemotherapy (2008) (2)
- Pharmacokinetic modeling of the in vivo fate of long-circulating liposomes in rats. (2002) (2)
- MR imaging of avb3-expression in tumor bearing mice using RGD-conjugated paramagnetic and fluorescent liposomes (2004) (2)
- Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12 (2017) (2)
- Poly(2-(dimethylamino)ethyl methacrylate)-Based Polymers for the Delivery of Genes In Vitro and In Vivo (2004) (2)
- Immunoliposome-Mediated Delivery of Chemotherapeutics (1990) (2)
- The Effect of Microbubble-Assisted Ultrasound on Molecular Permeability across Cell Barriers (2022) (2)
- Complement activation as a bioequivalence issue relevant to generic liposome development (2015) (2)
- Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages (2022) (2)
- Long‐Circulating and Passively Tumor‐Targeted Polymer‐Drug Conjugates Improve the Efficacy and Reduce the Toxicity of Radiochemotherapy (2010) (2)
- siRNA as a new drug: intellectual property (2005) (2)
- In Vivo Assessment of Thermosensitive Liposomes for the Treatment of Port Wine Stains by Antifibrinolytic Site-Specific Pharmaco-Laser Therapy (2020) (2)
- Interaction of liposomes with proteins measured by surface plasmon resonance correlates with their in vivo circulation time. (2010) (2)
- Liposome advances - Sixth International Conference. Progress in drug and vaccine delivery. (2004) (2)
- Use of Radiolabeled Liposomes for Imaging of Infection and Inflammation (2008) (1)
- Bone Marrow Neutralizes Human Regulatory T-Cells to Permit Graft-Versus-Tumor Immunity In Humanized Mice (2010) (1)
- 355 Targeting the STAT6 pathway to inhibit tumor-associated macrophages-induced tumor growth and metastasis in breast cancer (2015) (1)
- Liposomal Drug Delivery: Possibilities for Manipulation (1994) (1)
- In-vivo delivery of DNA and protein using conceptually new cationic, sunfish', amphiphiles. (2005) (1)
- OP-5. Imaging focal infection in granulocytopaenic rats: Comparison of 67Ga and three 99Tcm-labelled agents (1997) (1)
- JOINT TARGETING OF GLUCOCORTICOIDS WITH LONG-CIRCULATING LIPOSOMES INDUCES COMPLETE REMISSION OF EXPERIMENTAL ARTHRITIS (2003) (1)
- Cancer Therapy : Preclinical Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow : A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells (2013) (1)
- Local sustained delivery of bupivacaine HCl from a new castor oil-based nanoemulsion system (2018) (1)
- The role of thromboxane A2 in complement activation-related pseudoallergy (2017) (1)
- PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis (2018) (1)
- Nanoparticles for targeted delivery of anticancer agents (2005) (1)
- Quantitative Assessment of the Impact of Ex Vivo Manipulation on the In Vivo Functionality of Human T Cells in RAG2−/− γc−/− mice. (2004) (1)
- Induction of Potent Anti-Tumor Effects by Original and TCR-Redirected CD4 + Cytotoxic T Cells. (2009) (1)
- Liposomes for drug targeting to endothelial cells at inflammatory sites (2003) (1)
- Targeting of liposomes to angiogenic endothelial cells. (2002) (1)
- Liposomal corticosteroid as targeted anti-inflammatory nanomedicine (2008) (1)
- Therapeutic nanomedicine: Liposomal corticosteroid as targeted antiinflammatory nanomedicine (2008) (1)
- Physicochemical and Biological Evaluation of siRNA Polyplexes Based on PEGylated Poly(amido amine)s (2011) (1)
- Intraperitoneal administration of mitoxantrone liposomes provides advantageous pharmacokinetics in comparison to i.v. or i.p. administration of free drug : a study in a rat model (1996) (1)
- Oral Presentations—Abstracts (2003) (1)
- SUSTAINED CYTOKINE DELIVERY FOR CANCER VACCINATION (1997) (1)
- Biodistribution and Therapeutic Utility of Liposomal Drug Carrier Systems (1993) (1)
- LIPOSOMAL INTERLEUKIN-2 (IL-2) AND CHEMOTHERAPEUTICS IN LOCOREGIONAL AND SYSTEMIC TREATMENT OF EXPERIMENTAL TUMORS (1997) (1)
- Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity (2014) (1)
- COMPLEMENT ACTIVATION - RELATED HYPERSENSITIVITY REACTIONS CAUSED BY PEGYLATED LIPOSOMES SEARCH FOR AN ALTERNATIVE LONG-CIRCULATING LIPOSOME FORMULATION WITHOUT COMPLEMENT ACTIVATION (2003) (1)
- Effect of multiple injections on pharmacokinetics and biodistribution of sterically stabilized liposomes (1998) (1)
- Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial (2021) (1)
- Assessing early effects of angiogenesis inhibitors using MR molecular imaging (2005) (1)
- High systemic availability of core-crosslinked polymeric micelles after subcutaneous administration. (2016) (1)
- DRUG TARGETING BY LONG-CIRCULATING LIPOSOMAL GLUCOCORTICOIDS INCREASES THERAPEUTIC EFFICACY IN A MODEL OF MULTIPLE SCLEROSIS CHAPTER (2003) (0)
- Silencing Proteins: Nanotechnological Approaches to Deliver siRNA for Cancer Therapy (2006) (0)
- O 8 Liposomes and cancer immunotherapy (1996) (0)
- Image-guided Polymeric Nanomedicines for Radiochemotherapy (2011) (0)
- HIFU-CHEM- High Intensity Focused Ultrasound for tumor-targeted temperature-responsive drug delivery (2014) (0)
- Nanotheranostics: combining non-invasive imaging with tumor-targeted drug delivery to individualize (chemo-) therapeutic interventions (2012) (0)
- Diagnostic utility and pharmacokinetics of PEG-liposomes (1999) (0)
- Imaging experimental intra-abdominal abscesses with Tc-99m-PEG-liposomes and Tc-99m-HYNIC-lgG (1998) (0)
- DOXORUBICIN (ADRIAMYCIN) CONTAINING LIPOSOMES AS DRUG CARRIER SYSTEMS IN CANCER-CHEMOTHERAPY - STUDIES ON THEIR MODE OF ACTION INVIVO (1985) (0)
- 12 Use of Radiolabeled Liposomes for Imaging of Infection and Inflammation (0)
- 834. Tumor Targeted Gene Delivery Using a Non-Viral Vector System (2004) (0)
- Liposomal targeting of immunomodulatory compounds to inflamed sites (2003) (0)
- Improving therapy for TB (2007) (0)
- Ligand-targeted liposomes directed against tumor vasculature to attack solid tumors (2000) (0)
- Systemically delivered glucocorticoid liposomes suppress bone erosion and inhibit osteoclast activation in synovium and bone marrow during experimental murine arthritis (2010) (0)
- 849 Optimization of a GM3-containing liposomal vaccine that delivers antigen to CD169+ splenic macrophages (2020) (0)
- First clinical experience with technetium-99m labeled PEG-liposomes for the detection of infection and inflammation (1998) (0)
- Treatment of Tumors Using Cytostatic-containing Liposomes (1991) (0)
- Molecular MRI of neurovascular inflammation in a mouse stroke model using bimodal ICAM-1 targeted nanoparticles (2010) (0)
- In vitro Characterization of a Lipidic Delivery System for Anti-angiogenic siRNA (2013) (0)
- DOXORUBICIN (ADRIAMYCIN) CONTAINING LIPOSOMES AS DRUG DELIVERY SYSTEMS (1985) (0)
- Multi-parametric MRI assessment of the anti-angiogenic effects of liposome-encapsulated glucocorticoids (2010) (0)
- Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis (2023) (0)
- Yamanouchi LIPOSOMAL TARGETING OF GLUCOCORTICOIDS TO SYNOVIAL LINING CELLS STRONGLY INCREASES THERAPEUTIC BENEFIT IN COLLAGEN TYPE II ARTHRITIS CHAPTER (2003) (0)
- Bioinspired cell-derived nanovesicles protect the heart from ischemia reperfusion injury (2020) (0)
- Comparison of Polymeric siRNA Nanocarriers in a Murine LPS-Activated Macrophage Cell Line: Gene Silencing, Toxicity and Off-Target Gene Expression (2011) (0)
- Distribution of technetium-99 m PEG-liposomes during oligofructose-induced laminitis 1 development in horses 2 (2015) (0)
- Imaging, biodistribution and safety of Tc-99m PEG-liposomes in horses (2010) (0)
- 150 MicroRNA-199a and 214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor (2015) (0)
- Hemocompatibility Assessment of two siRNA Nanocarrier Formulations (2014) (0)
- Liposomal encapsulation of cytokines to achieve paracrine cytokine delivery in tumor vaccine development (1998) (0)
- Targeted Delivery Systems Of siRNA To Inhibit Tumor Angiogenesis (2006) (0)
- Design of methacrylate-based polyplexes for tumor targeting Review Article (2004) (0)
- Targeted multimodal liposomes for imaging and radionuclide therapy (2005) (0)
- THERAPEUTIC UTILITY OF LONG CIRCULATING LIPOSOMES (1993) (0)
- Intravenous 99m-Technetium Liposomes in horses: A safety and biodistribution study (2009) (0)
- Related articles (2013) (0)
- Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial (2021) (0)
- Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization (2021) (0)
- Microbubble-Assisted Ultrasound for Drug Delivery to the Retina in an Ex Vivo Eye Model (2023) (0)
- Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis (2018) (0)
- Cellular association and internalization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes (2003) (0)
- Achieving curative treatment of advanced (2019) (0)
- Lipid-coated iron oxide : A versatile , biocompatible and multimodal material for cellular imaging (2009) (0)
- Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose 1 (2000) (0)
- Π -Conjugated Polymeric Micelles Potentiate Docetaxel Therapy in Advanced-Stage Gastrointestinal Cancer (2021) (0)
- Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives (2022) (0)
- Liposomal encapsulation enhances the antitumor efficacy of the vascular disrupting agent in murine B16. F10 melanoma (2009) (0)
- LIPOSOME-ENCAPSULATED PREDNISOLONE PHOSPHATE INHIBITS TUMOR GROWTH IN MICE (2003) (0)
- Evaluation of efficacy of liposomal triamcinolone acetonide as targeted anti-inflammatory treatment in a rabbit model of experimental uveitis (2016) (0)
- Liposomal delivery of the glucocorticoid dexamethasone inhibits the growth of malignant bone lesions from human prostate cancer (2015) (0)
- Liposomal targeting of peptides and proteins (1996) (0)
- Stealth™ Therapeutic Systems: Rationale and Strategies (1998) (0)
- Transferrin-Guided Polymersomal Doxorubicin for Potent and Low-Toxic Chemotherapy of Orthotopic Hepatocellular Carcinoma in Vivo (2019) (0)
- Targeted nanomedicine and nanotheranostics (2015) (0)
- Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress (2020) (0)
- Editorial to European Workshop on Particulate Systems in Nanomedicine (2014). (2015) (0)
- Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies (2012) (0)
- Clinical Cancer esearch cer Therapy : Preclinical dication of Medullary Multiple Myeloma by CD 4 + Cytotoxic an T Lymphocytes Directed at a Single Minor R ocompatibility Antigen (2010) (0)
- double-mutant mice-/-c γ-/-transfer of human peripheral blood mononuclear cells in RAG 2 A new xenograft model for graft-versus-host disease by intravenous (2003) (0)
- Interview with Gert Storm. (2013) (0)
- Evaluation of paclitaxel-loaded polymeric nanoparticles in 3D tumor model: impact of tumor stroma on penetration and efficacy (2023) (0)
- 1 Noninvasive Optical Imaging of 2 Nanomedicine Biodistribution (2012) (0)
- Cancer nanomedicine meets immunotherapy: opportunities and challenges (2020) (0)
- Intravenous administration of siRNA for therapeutic applications (2007) (0)
- Targeting liver inflammation using CD64-targeted lipid nanoparticles as a novel drug delivery system (2018) (0)
- Imaging experimental intra-abdominal abscesses with technetium-99m-PEG-liposomes and technetium-99m-HYNIC-immunoglobulin G (1998) (0)
- Osteoimmunomodulatory Gelma/ Liposome Coatings to Promote Bone Regeneration of Orthopedic Implants (2022) (0)
- 176 Specific targeting of anti-miRNA oligonucleotides to pancreatic stellate cells via a syndecan dependent uptake mechanism (2015) (0)
- Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis (2022) (0)
- THERAPEUTIC INDEX OF GLUCOCORTICOIDS CAN BE OPTIMIZED BY ENCAPSULATING HIGH-CLEARANCE GLUCOCORTICOIDS IN LONG-CIRCULATING LIPOSOMES (2003) (0)
- Gene delivery to tumors using polymeric carriers (2007) (0)
- Intra-articular treatment with triamcinolone acetonide-loaded liposomes in the rat high-fat diet groove model (2019) (0)
- Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics (2022) (0)
- European Commission-supported development of targeted nanomedicines: did MediTrans make a difference? (2011) (0)
- ReviewArticle Targeted Delivery of siRNA (2006) (0)
- Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative (2017) (0)
- Development of an optimized immuno-enzymosome formulation for application in cancer therapy (1998) (0)
- Multimodality molecular imaging of tumor angiogenesis using quantum dots (2005) (0)
- Liposome-encapsulated berberine treatment reduces adverse ventricle remodeling after myocardial infarction (2016) (0)
- P and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes (2003) (0)
- Prolonged systemic delivery of peptides by Stealth® liposomes (1992) (0)
- Design and development of nanomedicines to treat atherosclerosis: A cross platform head-to-head theranostic study (2016) (0)
- The intravenous administration of 99m-technetium liposomes to healthy adult horses (2009) (0)
- Abstract 11287: Translation of an Anti-Inflammatory Nanomedical Treatment for Atherosclerosis: First Randomized Clinical Trial in Patients With Cardiovascular Disease (2013) (0)
- Thermosensitive Liposomes Encapsulated in a Thermoresponsive Hydrogel for On-Demand Release : The Lipogel System (2014) (0)
- Optimization of immunoenzymosomes for the treatment of ovarian carcinoma (abstract) (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gert Storm,?
Gert Storm, is affiliated with the following schools:
